posted on 2024-08-12, 09:20authored byMaxim Shevtsov, Danila Bobkov, Natalia Yudintceva, Ruslana Likhomanova, Alexander Kim, Evegeniy Fedorov, Viacheslav Fedorov, Natalia Mikhailova, Elena Oganesyan, Sergey Shabelnikov, Oleg Rozanov, Timur Garaev, Nikolay Aksenov, Alla Shatrova, Artem Ten, Anastasiya Nechaeva, Daria Goncharova, Rustam Ziganshin, Anastasiya Lukacheva, Daria Sitovskaya, Alexey Ulitin, Emil Pitkin, Konstantin Samochernykh, Evgeny Shlyakhto, Stephanie E. Combs
Evaluation of biomarkers co-localization.
History
ARTICLE ABSTRACT
Molecular chaperones, especially 70 kDa heat shock protein, in addition to their intracellular localization in cancer cells, can be exposed on the surface of the plasma membrane. We report that the membrane-associated chaperone mHsp70 of malignant brain tumors is required for high migratory and invasive activity of cancer cells. Live-cell inverted confocal microscopy of tumor samples from adult (n = 23) and pediatric (n = 9) neurooncologic patients showed pronounced protein expression on the membrane, especially in the perifocal zone. Mass spectrometry analysis of lipid rafts isolated from tumor cells confirmed the presence of the protein in the chaperone cluster (including representatives of other families, such as Hsp70, Hsc70, Hsp105, and Hsp90), which in turn, during interactome analysis, was associated with proteins involved in cell migration (e.g., Rac1, RhoC, and myosin-9). The use of small-molecule inhibitors of HSP70 (PES and JG98) led to a substantial decrease in the invasive potential of cells isolated from a tumor sample of patients, which indicates the role of the chaperone in invasion. Moreover, the use of HSP70 inhibitors in animal models of orthotopic brain tumors significantly delayed tumor progression, which was accompanied by an increase in overall survival. Data demonstrate that chaperone inhibitors, particularly JG98, disrupt the function of mHsp70, thereby providing an opportunity to better understand the diverse functions of this protein and offer aid in the development of novel cancer therapies.
Membrane-bound mHsp70 is required for brain tumor cell migration and invasion and therefore could be employed as a target for anticancer therapies.